Cargando…

Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo

BACKGROUND: Lung adenocarcinoma (LUAD) is one of the most common malignancies worldwide. However, the molecular mechanism of LUAD tumorigenesis and development remains unclear. The purpose of this study was to comprehensively illustrate the role of GTF2E2 in the growth and progression of LUAD. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Guoshu, Zhu, Donglin, Bian, Yunyi, Huang, Yiwei, Zhan, Cheng, Yang, Yong, Wang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989205/
https://www.ncbi.nlm.nih.gov/pubmed/33757492
http://dx.doi.org/10.1186/s12935-021-01878-z
_version_ 1783668910643478528
author Bi, Guoshu
Zhu, Donglin
Bian, Yunyi
Huang, Yiwei
Zhan, Cheng
Yang, Yong
Wang, Qun
author_facet Bi, Guoshu
Zhu, Donglin
Bian, Yunyi
Huang, Yiwei
Zhan, Cheng
Yang, Yong
Wang, Qun
author_sort Bi, Guoshu
collection PubMed
description BACKGROUND: Lung adenocarcinoma (LUAD) is one of the most common malignancies worldwide. However, the molecular mechanism of LUAD tumorigenesis and development remains unclear. The purpose of this study was to comprehensively illustrate the role of GTF2E2 in the growth and progression of LUAD. METHODS AND MATERIALS: We obtained the mRNA expression data from The Cancer Genome Atlas, Gene Expression Omnibus database, and our institution. Systematic bioinformatical analyses were performed to investigate the expression and prognostic value of GTF2E2 in LUAD. The results were validated by immunohistochemistry and qPCR. The effect of knocking down GTF2E2 using two short hairpin RNAs was investigated by in vitro and in vivo assays. Subsequently, shotgun liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) analyses were applied to identified potential GTF2E2 interacting proteins, and the downstream molecular mechanisms of GTF2E2-signaling were further explored by a series of cellular functional assays. RESULTS: We found that GTF2E2 expression was significantly increased in LUAD tissue compared with adjacent normal tissue and was negatively associated with patients’ overall survival. Besides, we demonstrated that GTF2E2 knockdown inhibited LUAD cell proliferation, migration, invasion, and promote apoptosis in vitro, as well as attenuated tumor growth in vivo. Results from LC–MS/MS suggested that RPS4X might physically interact with GTF2E2 and mediated GTF2E2’s regulatory effect on LUAD development through the mTOR pathway. CONCLUSION: Our findings indicate that GTF2E2 promotes LUAD development by activating RPS4X. Therefore, GTF2E2 might serve as a promising biomarker for the diagnosis and prognosis of LUAD patients, thus shedding light on the precise and personalized therapy for LUAD in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-01878-z.
format Online
Article
Text
id pubmed-7989205
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79892052021-03-25 Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo Bi, Guoshu Zhu, Donglin Bian, Yunyi Huang, Yiwei Zhan, Cheng Yang, Yong Wang, Qun Cancer Cell Int Primary Research BACKGROUND: Lung adenocarcinoma (LUAD) is one of the most common malignancies worldwide. However, the molecular mechanism of LUAD tumorigenesis and development remains unclear. The purpose of this study was to comprehensively illustrate the role of GTF2E2 in the growth and progression of LUAD. METHODS AND MATERIALS: We obtained the mRNA expression data from The Cancer Genome Atlas, Gene Expression Omnibus database, and our institution. Systematic bioinformatical analyses were performed to investigate the expression and prognostic value of GTF2E2 in LUAD. The results were validated by immunohistochemistry and qPCR. The effect of knocking down GTF2E2 using two short hairpin RNAs was investigated by in vitro and in vivo assays. Subsequently, shotgun liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) analyses were applied to identified potential GTF2E2 interacting proteins, and the downstream molecular mechanisms of GTF2E2-signaling were further explored by a series of cellular functional assays. RESULTS: We found that GTF2E2 expression was significantly increased in LUAD tissue compared with adjacent normal tissue and was negatively associated with patients’ overall survival. Besides, we demonstrated that GTF2E2 knockdown inhibited LUAD cell proliferation, migration, invasion, and promote apoptosis in vitro, as well as attenuated tumor growth in vivo. Results from LC–MS/MS suggested that RPS4X might physically interact with GTF2E2 and mediated GTF2E2’s regulatory effect on LUAD development through the mTOR pathway. CONCLUSION: Our findings indicate that GTF2E2 promotes LUAD development by activating RPS4X. Therefore, GTF2E2 might serve as a promising biomarker for the diagnosis and prognosis of LUAD patients, thus shedding light on the precise and personalized therapy for LUAD in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-01878-z. BioMed Central 2021-03-23 /pmc/articles/PMC7989205/ /pubmed/33757492 http://dx.doi.org/10.1186/s12935-021-01878-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Bi, Guoshu
Zhu, Donglin
Bian, Yunyi
Huang, Yiwei
Zhan, Cheng
Yang, Yong
Wang, Qun
Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
title Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
title_full Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
title_fullStr Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
title_full_unstemmed Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
title_short Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
title_sort knockdown of gtf2e2 inhibits the growth and progression of lung adenocarcinoma via rps4x in vitro and in vivo
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989205/
https://www.ncbi.nlm.nih.gov/pubmed/33757492
http://dx.doi.org/10.1186/s12935-021-01878-z
work_keys_str_mv AT biguoshu knockdownofgtf2e2inhibitsthegrowthandprogressionoflungadenocarcinomaviarps4xinvitroandinvivo
AT zhudonglin knockdownofgtf2e2inhibitsthegrowthandprogressionoflungadenocarcinomaviarps4xinvitroandinvivo
AT bianyunyi knockdownofgtf2e2inhibitsthegrowthandprogressionoflungadenocarcinomaviarps4xinvitroandinvivo
AT huangyiwei knockdownofgtf2e2inhibitsthegrowthandprogressionoflungadenocarcinomaviarps4xinvitroandinvivo
AT zhancheng knockdownofgtf2e2inhibitsthegrowthandprogressionoflungadenocarcinomaviarps4xinvitroandinvivo
AT yangyong knockdownofgtf2e2inhibitsthegrowthandprogressionoflungadenocarcinomaviarps4xinvitroandinvivo
AT wangqun knockdownofgtf2e2inhibitsthegrowthandprogressionoflungadenocarcinomaviarps4xinvitroandinvivo